ClinicalTrials.Veeva

Menu

Cardiorenal Syndrome in End-Stage Kidney Disease

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Cardiorenal Syndrome
Heart Disease
End-stage Renal Disease

Study type

Observational

Funder types

Other

Identifiers

NCT02238093
106-13-HYMC

Details and patient eligibility

About

Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality.

The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.

Enrollment

270 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • End-stage renal patients

Exclusion criteria

  • Cancer patients

Trial design

270 participants in 1 patient group

Dialysis Patients
Description:
End-stage renal disease patients undergoing dialysis at the Hillel Yaffe Medical Center.

Trial contacts and locations

1

Loading...

Central trial contact

Noa Berar-Yanay, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems